Insulizen

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Insulizen
Generic name
INSULIN RESISTANCE REDUCER, INSULIN RECEPTOR RESTORE, AND BLOOD SUGAR LEVEL BALANCE
Manufacturer
HCBIOPHARM LLC
Product type
HUMAN OTC DRUG
SPL set ID
d10353a9-0543-831e-e053-2a95a90a4e91
SPL ID
4e3805b9-f7bf-4d36-e063-6294a90a51ff
Version
6
Effective date
2026-03-30
Source export date
2026-10-12
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/b25dad4aaef9c88f0e827394a34fbbd1ce7d71422fa46b5d1e123befad498c1d/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:45:51
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning Individuals with known medical conditions should consult a doctor prior to using this.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.